- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02894190
Development and Validation of the BVQ
July 25, 2022 updated by: Fondazione Don Carlo Gnocchi Onlus
Development and Validation of the Beliefs About Ventilation Questionnaire (BVQ)
The main aim of this study is the development of the Beliefs about Ventilation Questionnaire (BVQ).
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy, 20148
- IRCCS Santa Maria Nascente, Fondazione Don Carlo Gnocchi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People with obstructive or restrictive respiratory diseases
Description
Inclusion Criteria:
- Age ≥ 18 years old
- Indication to Non Invasive Ventilation (NIV), in three slots: <4; >4 e <12; <12 hours
- Outpatients or Inpatients
- Obstructive or restrictive reparatory disorder
- Voluntary agreement to be involved in the Study
Exclusion Criteria:
- Psychiatric Disorder
- Glasgow Coma Scale (CGS) <14
- Pure Obstructive Sleep Apnea Syndrome (OSAS)
- Tracheostomy with Invasive Ventilation (TIV) o Invasive Ventilation (IV)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline in adherence NIV in COPD patients at 3, 6 and 12 months as measured by the Beliefs of Ventilation Questionnaire (BVQ)
Time Frame: Baseline + After 3, 6 and 12 months following the recruitment
|
Baseline + After 3, 6 and 12 months following the recruitment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Feasibility and acceptability of the questionnaire (duration / missing data)
Time Frame: Baseline + After 3, 6 and 12 months following the recruitment
|
Baseline + After 3, 6 and 12 months following the recruitment
|
Reliability over time of the questionnaire
Time Frame: Baseline + After 3, 6 and 12 months following the recruitment
|
Baseline + After 3, 6 and 12 months following the recruitment
|
External construct validity (The World Health Organization Quality of Life (WHOQOL); hours of Non Invasive Ventilation (NIV) prescribed, effective and referred by patients)
Time Frame: Baseline + After 3, 6 and 12 months following the recruitment
|
Baseline + After 3, 6 and 12 months following the recruitment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lopez-Campos JL, Jara-Palomares L, Munoz X, Bustamante V, Barreiro E. Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations. Ann Thorac Med. 2015 Apr-Jun;10(2):87-93. doi: 10.4103/1817-1737.151440.
- Ozyilmaz E, Ugurlu AO, Nava S. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med. 2014 Feb 13;14:19. doi: 10.1186/1471-2466-14-19.
- van Boven JF, Chavannes NH, van der Molen T, Rutten-van Molken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014 Jan;108(1):103-13. doi: 10.1016/j.rmed.2013.08.044. Epub 2013 Sep 11.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2016
Primary Completion (Actual)
December 31, 2018
Study Completion (Actual)
March 31, 2020
Study Registration Dates
First Submitted
September 5, 2016
First Submitted That Met QC Criteria
September 5, 2016
First Posted (Estimate)
September 9, 2016
Study Record Updates
Last Update Posted (Actual)
July 26, 2022
Last Update Submitted That Met QC Criteria
July 25, 2022
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDG_BVQ_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Respiratory Disease
-
Skane University HospitalLund University; The Swedish Research Council; ResMed; Vastra Gotaland Region; Region... and other collaboratorsNot yet recruitingInterstitial Lung Disease | Chronic Respiratory Failure With Hypoxia | Chronic Obstructive Pulmonary Disease Severe
-
Aveiro UniversityPrograma Operacional Inclusão Social e Emprego (POISE); Programa Operacional... and other collaboratorsCompletedLung Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Interstitial Lung Disease | Chronic Respiratory DiseasePortugal
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteRecruitingChronic Bronchitis | Chronic Obstructive Pulmonary Disease SevereUnited States
-
University Hospital, Gentofte, CopenhagenPhilips RespironicsUnknownChronic Obstructive Pulmonary Disease | Chronic Hypercapnic Respiratory Failure | Acute Exacerbation of Chronic Obstructive Airways DiseaseDenmark
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Albania, Argentina, Australia, Austria, Bosnia and Herzegovina, Chile, China, Czechia, Georgia, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian... and more
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownChronic Respiratory Failure | Chronic Obstructive Pulmonary Disease PatientsItaly
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI); Vertex Pharmaceuticals IncorporatedCompletedChronic Obstructive Pulmonary Disease | Chronic BronchitisUnited States
-
Genentech, Inc.RecruitingChronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisUnited States, Australia, United Kingdom, Canada